- Report
- February 2023
- 102 Pages
From €3064EUR$3,450USD£2,659GBP
- Report
- February 2023
- 107 Pages
North America
From €3064EUR$3,450USD£2,659GBP
- Report
- February 2023
- 221 Pages
Global
From €3952EUR$4,450USD£3,430GBP
- Report
- February 2023
- 121 Pages
Europe
From €3064EUR$3,450USD£2,659GBP
- Report
- February 2023
- 122 Pages
Asia Pacific
From €3064EUR$3,450USD£2,659GBP
- Report
- February 2023
- 106 Pages
Africa, Middle East
From €3064EUR$3,450USD£2,659GBP
- Report
- January 2023
- 158 Pages
Global
From €3952EUR$4,450USD£3,430GBP
- Report
- July 2021
- 148 Pages
Middle East, Africa
From €3064EUR$3,450USD£2,659GBP
- Report
- July 2021
- 151 Pages
Europe
From €3064EUR$3,450USD£2,659GBP
- Report
- May 2024
- 126 Pages
Global
From €2807EUR$3,160USD£2,435GBP
€3508EUR$3,950USD£3,044GBP
- Report
- May 2024
- 122 Pages
Global
From €2807EUR$3,160USD£2,435GBP
€3508EUR$3,950USD£3,044GBP
- Report
- April 2024
- 117 Pages
Global
From €2807EUR$3,160USD£2,435GBP
€3508EUR$3,950USD£3,044GBP
- Report
- January 2024
- 142 Pages
Global
From €3020EUR$3,400USD£2,620GBP
€3775EUR$4,250USD£3,276GBP
- Report
- December 2023
- 140 Pages
Global
From €3162EUR$3,560USD£2,744GBP
€3952EUR$4,450USD£3,430GBP
- Report
- May 2024
- 100 Pages
Africa
From €888EUR$1,000USD£771GBP
€1776EUR$2,000USD£1,541GBP
- Report
- April 2024
- 80 Pages
China
From €666EUR$750USD£578GBP
€1332EUR$1,500USD£1,156GBP
- Report
- April 2024
- 80 Pages
France
From €666EUR$750USD£578GBP
€1332EUR$1,500USD£1,156GBP
- Report
- April 2024
- 80 Pages
Germany
From €666EUR$750USD£578GBP
€1332EUR$1,500USD£1,156GBP
- Report
- April 2024
- 80 Pages
South Korea
From €666EUR$750USD£578GBP
€1332EUR$1,500USD£1,156GBP
From €666EUR$750USD£578GBP
€1332EUR$1,500USD£1,156GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more